Ticker Launch
Sign inTry it free

SPAC · Merger completed

Health Sciences Acquisitions Corp

Business combination with Immunovant Sciences Ltd.

Health Sciences Acquisitions Corp is a blank-check company (SPAC) that raised $100M in its initial public offering on May 10, 2019, listing on Nasdaq Capital Market. It completed its business combination with Immunovant Sciences Ltd. on Dec 18, 2019; the combined company is Immunovant, Inc. (IMVT). Morgan Stanley led the IPO, with Chardan and UBS. Loeb & Loeb advised the SPAC and Kirkland & Ellis advised the underwriters on the IPO.

Immunovant Sciences Ltd., a member of the Roivant family of companies, is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. It is the target of a business combination with Health Sciences Acquisitions Corporation.

Status
Merger completed
IPO date
May 10, 2019
IPO size
$100M
IPO exchange
Nasdaq Capital Market
Target
Immunovant Sciences Ltd.
Announced
Oct 2, 2019
Closed
Dec 18, 2019
Combined company
Immunovant, Inc. (IMVT)
IPO underwriters
Morgan Stanley, Chardan and UBS
SPAC counsel (IPO)
Loeb & Loeb
Underwriters' counsel (IPO)
Kirkland & Ellis

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Try it free for 7 daysOpen in Ticker Launch

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2019